Barclays’s Viemed Healthcare VMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Buy |
144,056
+95,726
| +198% | +$662K | ﹤0.01% | 2661 |
|
|
2025
Q1 | $352K | Sell |
48,330
-10,305
| -18% | -$75.1K | ﹤0.01% | 3035 |
|
|
2024
Q4 | $470K | Buy |
58,635
+5,196
| +10% | +$41.7K | ﹤0.01% | 3087 |
|
|
2024
Q3 | $392K | Buy |
53,439
+41,358
| +342% | +$303K | ﹤0.01% | 3125 |
|
|
2024
Q2 | $79K | Sell |
12,081
-12,172
| -50% | -$79.6K | ﹤0.01% | 3490 |
|
|
2024
Q1 | $229K | Sell |
24,253
-23,113
| -49% | -$218K | ﹤0.01% | 3273 |
|
|
2023
Q4 | $372K | Buy |
47,366
+40,930
| +636% | +$321K | ﹤0.01% | 3167 |
|
|
2023
Q3 | $43K | Sell |
6,436
-1,170
| -15% | -$7.82K | ﹤0.01% | 3661 |
|
|
2023
Q2 | $74K | Sell |
7,606
-7,790
| -51% | -$75.8K | ﹤0.01% | 3519 |
|
|
2023
Q1 | $149K | Buy |
15,396
+495
| +3% | +$4.79K | ﹤0.01% | 3319 |
|
|
2022
Q4 | $113K | Buy |
14,901
+13,117
| +735% | +$99.5K | ﹤0.01% | 3396 |
|
|
2022
Q3 | $11K | Buy |
+1,784
| New | +$11K | ﹤0.01% | 4153 |
|
|
2022
Q2 | – | Sell |
-5,749
| Closed | -$29K | – | 4931 |
|
|
2022
Q1 | $29K | Sell |
5,749
-37,225
| -87% | -$188K | ﹤0.01% | 4203 |
|
|
2021
Q4 | $225K | Buy |
42,974
+28,504
| +197% | +$149K | ﹤0.01% | 2794 |
|
|
2021
Q3 | $80K | Buy |
14,470
+9,991
| +223% | +$55.2K | ﹤0.01% | 3287 |
|
|
2021
Q2 | $32K | Sell |
4,479
-24,704
| -85% | -$176K | ﹤0.01% | 3580 |
|
|
2021
Q1 | $295K | Buy |
29,183
+4,752
| +19% | +$48K | ﹤0.01% | 2952 |
|
|
2020
Q4 | $190K | Sell |
24,431
-27,033
| -53% | -$210K | ﹤0.01% | 2720 |
|
|
2020
Q3 | $446K | Buy |
51,464
+32,570
| +172% | +$282K | ﹤0.01% | 2364 |
|
|
2020
Q2 | $181K | Buy |
+18,894
| New | +$181K | ﹤0.01% | 2858 |
|